Buchholtz, Kristine
Novo Nordisk (Denmark)
2 papers on CoChat
Most cited papers
- Verified
A Placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis
Newsome, P. N., Buchholtz, K., Cusi, K., Linder, M., Okanoue, T., Ratziu, V., Sanyal, A. J., Sejling, A.-S., & Harrison, S. A. (2021) · New England Journal of Medicine
Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management
Cited by 2,039
- Verified
Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial
Alkhouri, N., Herring, R., Kabler, H., Kayali, Z., Hassanein, T., Kohli, A., Huss, R. S., Zhu, Y., Billin, A. N., Damgaard, L. H., et al. (2022) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentHepatitis C virus research
Cited by 230
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free